Glenmark Pharmaceuticals launches `Minym Gel` for acne treatment
Glenmark Pharmaceuticals has launched India’s first topical Minocycline 4% Gel for the treatment of moderate to severe acne, under the brand name Minym. This is a potent antibacterial gel which exerts a strong anti-inflammatory action It also offers the lowest MIC90 (minimum Inhibitory Concentration at which it stops/prevents visible growth of 90% of isolates of bacteria) compared to the available topical antibacterial formulations.
Topical antibacterial formulations are some of the commonly used class of drugs for the treatment of acne. With no new topical formulations being launched over the last 30 years, there has been a gradual increase in resistance to the currently available topical antibacterial formulations. Minym Gel (Topical Minocycline 4% Gel) has been developed to address growing concerns in treatment of acne and is safe to use in patients above 9 years of age.
Glenmark Pharmaceuticals is a global research-led pharmaceutical company with presence across Generics, Specialty and OTC business with operations in over 50 countries.
